1. Proteomics-Based Approach Reveals the Involvement of SERPINB9 in Recurrent and Relapsed Multiple Myeloma
   Yao Chen et al, 2021, Journal of Proteome Research CrossRef
2. BAG2 overexpression correlates with growth and poor prognosis of esophageal squamous cell carcinoma
   Ying-Cai Hong et al, 2018, Open Life Sciences CrossRef
3. In vitro neutralization of yellow head virus infection in shrimp using recombinant PmYRP65 protein
   Sitthichai Kanokudom et al, 2018, Aquaculture CrossRef
4. Aponermin or placebo in combination with thalidomide and dexamethasone in the treatment of relapsed or refractory multiple myeloma (CPT-MM301): a randomised, double-blinded, placebo-controlled, phase 3 trial
   Zhongjun Xia et al, 2023, BMC Cancer CrossRef
5. Synergistic effects of rmhTRAIL and 17-AAG on the proliferation and apoptosis of multiple myeloma cells
   Jing Wang et al, 2018, Hematology CrossRef
6. Aponermin: First Approval
   Sohita Dhillon, 2024, Drugs CrossRef
7. Proteomics-inspired precision medicine for treating and understanding multiple myeloma
   Matthew Ho et al, 2020, Expert Review of Precision Medicine and Drug Development CrossRef
8. SAHA-induced TRAIL-sensitisation of Multiple Myeloma cells is enhanced in 3D cell culture
   A. Arhoma et al, 2017, Experimental Cell Research CrossRef